REG - Surgical Innovations - 3-year Exclusive UK distribution agreement

Surgical InnovationsAnnouncement

22/03/2021 07:05

RNS Number : 9375S
  
Surgical Innovations Group PLC
  
22 March 2021
  
 

 
Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")
 
3-year Exclusive UK distribution agreement
 
Elemental Healthcare Ltd sign an extended 3-year exclusive GB Distribution agreement

with Microline Surgical Inc.
 
Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces that its wholly owned subsidiary, Elemental Healthcare Ltd ("Elemental") has signed an additional three-year exclusive GB distribution agreement with Microline Surgical Inc. ("Microline") for the distribution in Great Britain of Microline instruments.  
 
Based near Boston, MA, U.S.A. Microline designs, manufactures and distributes high quality instruments aimed at the MIS market. Its portfolio of products is complementary to those offered by SI with a focus on the Resposable™ ethos of cost and sustainability. Elemental has a long established relationship with Microline, and recently announced a new 5-year USA distribution agreement with Microline for the Company's range of YelloPort+PlusTM and YelloPort EliteTM Access Devices.. 
 
Adam Power, Surgical Innovations Group Development Director, says: "We are very pleased to announce an exclusive agreement for a further three years to sell products manufactured by Microline Surgical. Microline is Elemental Healthcare's longest standing distribution partner as well as our largest, and shares the philosophy of sustainability in its products which will play such an important part in hospital decision-making in the years to come."
 
Isabelle Huysmans, General Manager Microline BV commented: "We are extremely happy to confirm the extension of the exclusive agreement for the next three years with our trusted partner, Elemental Healthcare, who embrace and embody our vision and values completely. Together we will continue to work passionately on sustainability to  provide solutions to improve the quality of life for everyone."
 
 
 
For further information please contact: 



Surgical Innovations Group plc


www sigroupplc com




David Marsh, CEO


Tel: 0113 230 7597




Charmaine Day, Co Sec & GFC


















N+1 Singer (Nominated Adviser & Broker)


Tel: 020 7496 3000




Aubrey Powell / Rachel Hayes/ Iqra Amin 


















Walbrook PR (Financial PR & Investor Relations)


Tel: 020 7933 8780 or si@walbrookpr.com




Paul McManus / Lianne Cawthorne


Mob: 07980 541 893 / 07584 391 303








 
About Surgical Innovations Group plc 
The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity. 
 
We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part re-usable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives. 
 
Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.


In addition, we design and develop medical devices for carefully selected OEM partners, and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena. 
 
We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment. 
 
The Group currently employs approximately 100 people across two sites in the UK. Product design, engineering and manufacturing are carried out at the SI site in Yorkshire. Commercial activities including marketing, UK distribution and international sales and marketing are based at Elemental Healthcare in Berkshire. 
 
Further information 
 
Further details of the Group's businesses and products are available on the following websites: 
 
www sigroupplc com
www surginno com
www elementalhealthcare co.uk 
 
To receive regular updates by email, please contact si@walbrookpr.com. 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCDKCBPCBKDCND